About the Editors | Bone Marrow Transplantation

Mohamad Mohty is Professor of Hematology and head of the Hematology and cellular therapy Department at the Saint-Antoine Hospital and University Pierre & Marie Curie (Paris, France).

Professor Mohty is also head of a translational research team (INSERM) at the Saint-Antoine Research centre in Paris and his research is focused on the pathophysiology and immunobiology of

normal and pathological antigen-presenting cells, especially the impact of immunomodulatory agents. He has a special clinical focus on the development of reduced-toxicity conditioning

regimens, immunotherapy and different aspects of therapy of multiple myeloma. Professor Mohty serves as Scientific Council Chair of the European Society for Blood and Marrow Transplantation

(EBMT) and the “Intergroupe Francophone du Myelome” (IFM).

Bipin Savani, MD, Vanderbilt University Medical Center, United States of America

Dr Savani’s area of specialization is in the treatment of hematological malignancies, stem cell transplantation/ cellular therapy, and his primary field of research is in the long-term

follow-up after transplantation/ cellular therapy, including regimen-related toxicity/ supportive care, and outcomes analysis of hematological malignancies, transplant and cellular therapy

recipients. Dr Savani has published over 500 peer-reviewed articles, reviews, book chapters, editorials, perspectives and commentaries in the field of hematological malignancies, stem cell

transplantation and cellular therapy. Dr Savani is currently leader of the Conditioning Regimen Subcommittee of the Acute Leukemia Working Party of the EBMT. He also serves as Co-Chair

Regimen-Related Toxicity and Supportive Care-CIBMTR and medical monitor for Blood and Marrow Transplant Clinical Trial Network (BMT-CTN). Dr Savani is a member of the ASH Committee on

Practice (COP) and a liaison member from the COP to the ASH Task Force on Immunotherapies subcommittee. He has recently edited several special issues for Seminars in Hematology, Hematology/

Oncology Clinics of North America and edited Wiley books entitled "Blood and Marrow Transplantation Long Term Management: Prevention and Complications" (first ed 2014, second ed May 2021)

and "Clinical guide to transplantation in lymphomas" (first ed 2015). Co-authored handbook on Leukemia (FAST FACTS: Leukemia, first ed 2019). He has served as a Foundation for the

Accreditation of Cellular Therapy (FACT) adults program clinical/ marrow collection facilities and Immune Effector Cell (IEC) inspector role since 2011.

Jakob R Passweg, MD, MS, Basel University Hospital, Switzerland